Literature DB >> 24620853

Vascular disorder in a competitive cyclist: a case report.

Judy K Clifft1, F Ann Coleman, Casey B Malone.   

Abstract

The purpose of this case report was to alert the physical therapist (PT) to the possibility of vascular disorders in endurance athletes with apparent musculoskeletal symptoms. A 33-year-old female injured her knee in a fall and described a history of progressive unilateral lower extremity (LE) pain and weakness, especially with running and cycling. She received LE stretching and strengthening but her symptoms persisted, so she stopped all activity. When she became symptomatic with minimal exertion, she went to a neurologist, but electromyographic (EMG)/nerve conduction velocity (NCV) studies were normal. Eventually, she was referred for vascular studies, which confirmed a diagnosis of external iliac artery endofibrosis. The patient underwent a right common iliac to common femoral artery bypass graft approximately 3 years after onset of initial symptoms. She ran a 5K race 3 weeks after surgery and returned to cycling after 4 weeks. Endofibrosis of the external iliac artery is an uncommon disorder but is most frequently diagnosed in high-performance athletes, especially cyclists. Physical therapists who practice in orthopedic settings should be aware of vascular conditions that mimic musculoskeletal disorders in endurance athletes. Vascular consult or referral may be necessary if PT interventions are ineffective in treating athletes with exercise-induced LE pain and weakness.

Entities:  

Keywords:  Athletic injuries; endofibrosis; iliac artery; vascular injuries

Mesh:

Year:  2014        PMID: 24620853     DOI: 10.3109/09593985.2014.898351

Source DB:  PubMed          Journal:  Physiother Theory Pract        ISSN: 0959-3985            Impact factor:   2.279


  1 in total

1.  Cyclist Endofibrosis (Exercise-Induced Arterial Endofibrosis) Treated by Drug-Coated Balloon Angioplasty.

Authors:  Ahmed S Zugail; Hossam I Shaabi; Slimane Idir; Jean-Pierre Becquemin
Journal:  Case Rep Vasc Med       Date:  2020-07-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.